Astute Capital PLC (Astute) is delighted to announce that it has won the ADVFN International Financial Award 2021 for the most innovative product. Astute has been recognised for its innovative approach to creating investment opportunities for its clients, most recently on the Frankfurt Stock Exchange through the use of listed secure asset backed bonds.
The 2021 ADVFN International Financial Awards recognise and celebrate the best of breed products and services from across the financial industry, both nationally and internationally.
Since its launch in 2016, Astute Capital has successfully grown its lending business through raising capital via its publicly listed bond programmes on Euronext Dublin and the Frankfurt Stock Exchange. The business gives its investors access to above-average, asset-backed returns, facilitated by its expertise in lending to Real Estate. Astute Works with companies that offer solid security but are perhaps restricted by timescales or multi asset security packages which larger banks simply won’t consider.
“Over the last few years, we have seen our business grow and remain resilient despite the current pandemic”, said Richard Symonds, Managing Director of Astute. “We are delighted to receive this award and it provides further credibility to our business model. We believe in offering attractive investment products as well as being open to grow our loan business”.
Astute Capital has firmly established itself within this niche, allowing it to achieve strong returns supported by a robust security structure and lending policies. The management team is comprised of experienced industry experts. This ensures that strict corporate governance and compliance is maintained at all times. Their structure includes a credit committee with independent members and supported by an entirely independent Risk and Oversight Committee made up of solicitors and compliance advisors.
Email: [email protected]
Country: United Kingdom
The sole purpose of the release is to announce the award achieved by Astute Capital. Neither does the PR intends to sell anything, nor does the information constitute advice or an offer to buy.
The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.